ANTIBIOPROPHYLAXIS AND ANTIBIOTHERAPY IN ABDOMINAL SURGERY – SHORT REVIEW
Abstract
Surgical site infection (SSI) represents a concerning for all surgeons because both the unfavorable impact on health care costs and risk factors that increase the durations of wound healing and SSI rate. A review of PubMed, Scopus and Google Scholar has been made. The keywords used were related to surgical site infection prevetion. SSIs have a raised incidence in abdominal surgery because of the fact that many types of bacterias live in the gastrointestinal tract and during a surgical procedure some may escape and cause an infection. There is a high risk of postoperatory infections in gastric surgery due to intestinal anastomoses which are predisposed to leakage. In hernia repair surgery there is a higher rate of SSIs than expected for a clean procedure, and one risk factor may be represented by the prosthetic device used. On the other hand, in laparoscopic cholecystectomy, there is a very low risk of SSI and antibioprophylaxis is not recommended. But the most contaminated procedure with the highest risk of infectious complications is colorectal surgery, which requieres a combination of antibiotics because of the numerous types of microorganism. Abdominal surgery comprises different techniques and involves most elements of the gastrointestinal tract. Some procedures need antibiotic prophylaxis and in others antibiotic administration is even prohibited. The most effective antibiotics are first and second-generation cephalosporins.
References
[2] R. L. Nichols, “Preventing surgical site infections: A surgeon’s perspective,” Emerg. Infect. Dis., vol. 7, no. 2, pp. 220–224, 2001.
[3] M. Spear, “Risk factors for surgical site infections,” Plast. Surg. Nurs., vol. 28, no. 4, pp. 201–204, 2008.
[4] T. G. Weiser, J. D. Forrester, and J. A. Forrester, “Tactics to Prevent Intra-Abdominal Infections in General Surgery,” Surg. Infect. (Larchmt)., vol. 20, no. 2, pp. 1–7, 2019.
[5] B. Allegranzi et al., “New WHO recommendations on intraoperative and postoperative measures for surgical site infection prevention: an evidence-based global perspective,” Lancet Infect. Dis., vol. 16, no. 12, pp. e288–e303, 2016.
[6] K. Morikane, H. Honda, and S. Suzuki, “Factors associated with surgical site infection following gastric surgery in Japan,” Infect. Control Hosp. Epidemiol., vol. 37, no. 10, pp. 1167–1172, 2016.
[7] H. Xiao, Y. Xiao, H. Quan, W. Liu, S. Pan, and Y. Ouyang, “Intra-abdominal infection after radical gastrectomy for gastric cancer: Incidence, pathogens, risk factors and outcomes,” Int. J. Surg., vol. 48, pp. 195–200, 2017.
[8] G. Development, Antimicrobial Prophylaxis in Surgery. 2013.
[9] T. Boonchan, C. Wilasrusmee, M. Mcevoy, J. Attia, and A. Thakkinstian, “Network meta-analysis of antibiotic prophylaxis for prevention of surgical-site infection after groin hernia surgery,” pp. 106–117, 2017.
[10] T. Mazaki et al., “A randomized trial of antibiotic prophylaxis for the prevention of surgical site infection after open mesh-plug hernia repair,” Am. J. Surg., vol. 207, no. 4, pp. 476–484, 2014.
[11] C. C. Register, “Antibiotic Prophylaxis in Patients Undergoing Open Mesh Repair of Inguinal Hernia :,” pp. 359–365.
[12] C. Is and I. T. Worth, “ANTIBIOTIC PROPHYLAXIS IN LAPAROSCOPIC,” vol. 29, no. 3, pp. 170–172, 2016.
[13] J. N. Shah, S. B. Maharjan, and S. Paudyal, “Routine use of antibiotic prophylaxis in low-risk laparoscopic cholecystectomy